Determine progression-free survival at 24 weeks 24 weeks [clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c]

Determine progression-free survival at 24 weeks 24 weeks [clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c]

Visit NovartisClinicalTrials.com: Pre-qualify for a trial, and view a list of trials and participating study centers.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c
Efficacy and Safety Study of Panobinostat in Patients With Metastatic Hormone Refractory Prostate Cancer [clinicaltrials:NCT00667862]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Determine progression-free survival at 24 weeks 24 weeks [clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c]

Visit NovartisClinicalTrials.com: Pre-qualify for a trial, and view a list of trials and participating study centers.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c
Bio2RDF identifier
5b66b2f994c0be136c46bfa376b6200c
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c
measure [clinicaltrials_vocabulary:measure]
Determine progression-free survival at 24 weeks
time frame [clinicaltrials_vocabulary:time-frame]
description
Visit NovartisClinicalTrials.c ...... d participating study centers.
identifier
clinicaltrials_resource:5b66b2f994c0be136c46bfa376b6200c
title
Determine progression-free survival at 24 weeks 24 weeks
@en
inDataset
type
label
Determine progression-free sur ...... 6b2f994c0be136c46bfa376b6200c]
@en